Showing results (71-80 of 172) with videos related to
Sort By:
Pageof 18
The Journal of ECT|January 11, 2013
Electroconvulsive therapy teaching in Canada: cause for concernSimon Patry, Peter Graf, Nicholas John Delva, et al.Social Psychiatry and Psychiatric Epidemiology|February 27, 2010
Public knowledge, beliefs and attitudes towards patients with schizophrenia: Buenos AiresEduardo Adrian Leiderman, Gustavo Vazquez, Candela Berizzo, et al.Personality and Mental Health|May 19, 2021
Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN-BIND 1 reportTimothy A Allen, Kate L Harkness, Raymond W Lam, et al.BMJ Open|December 29, 2022
Association of intranasal esketamine, a novel 'standard of care' treatment and outcomes in the management of patients with treatment-resistant depression: protocol of a prospective cohort observational study of naturalistic clinical practiceGustavo Vazquez, Gilmar Gutierrez, Joshua Rosenblat, et al.Current Pharmaceutical Design|June 12, 2012
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response predictionSidney H Kennedy, Jonathan Downar, Kenneth R Evans, et al.CNS Spectrums|December 12, 2022
The concept of "metabolic jet lag" in the pathophysiology of bipolar disorder: implications for research and clinical careElena Koning, Alexandra McDonald, Alexander Bambokian, et al.Journal of Affective Disorders|November 10, 2021
What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelinesFabiano A Gomes, Raphael O Cerqueira, Yena Lee, et al.BMJ Open|June 23, 2024
PRECISE trial (Pain RElief Combination Intervention StratEgies): protocol for the clinical trial of a pregabalin-melatonin combination for fibromyalgiaIan Gilron, Chris DeBow, Hala Elkerdawy, et al.The International Journal of Neuropsychopharmacology|December 11, 2019
Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 ReportAntoine Yrondi, Laura M Fiori, Benicio N Frey, et al.Psychological Medicine|September 18, 2018
Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 reportTimothy A Allen, Raymond W Lam, Roumen Milev, et al.Pageof 18